Cytoskeletal pathologies of Alzheimer disease

Cell Motility and the Cytoskeleton

Volumn 66, Issue 8, 2009, Pages 635-649

  Bamburg, James R ^a   Bloom, George S ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Actin; Alzheimer disease; Amyloid beta; Cofilin; Microtubule; Tau

Indexed keywords

ACTIN BINDING PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; COFILIN; G ACTIN; TAU PROTEIN;

ALZHEIMER DISEASE; CYTOSKELETON; HUMAN; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SENILE PLAQUE; SIGNAL TRANSDUCTION; SPINE;

ACTIN DEPOLYMERIZING FACTORS; ACTINS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CYTOSKELETON; HUMANS; MICROTUBULES;

EID: 67749133983     PISSN: 08861544     EISSN: 10970169     Source Type: Journal    
DOI: 10.1002/cm.20388     Document Type: Review

References (175)

1. Agnew BJ, Minamide LS, Bamburg JR. 1995. Reactivation of phosphorylated actin depolymerizing factor and identification of the regulatory site. J Biol Chem 270:17582-17587.
2. Alzheimer A. 1907. Uber eine eigenartige Erkankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und phychish-Gerichtliche Medizin, Berlin. 64:146-148.
3. Anderton BH, Breinburg D, Downes MJ, Green PJ, Tomlinson BE, Ulrich J, Wood JN, Kahn J. 1982. Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature 298:84-86. (Pubitemid 12087486)
4. Andreadis A. 2005. Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim Biophys Acta 1739:91-103. (Pubitemid 40018532)
5. Andrianantoandro E, Pollard TD. 2006. Mechanism of actin filament turnover by severing and nucleation at different concentrations of ADF/cofilin. Mol Cell 24:13-23. (Pubitemid 44466682)
6. Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O, Caroni P. 1998. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393:805-809. (Pubitemid 28299494)
7. Arias C, Becerra-Garcia F, Tapia R. 1998. Glutamic acid and Alzheimer's disease. Neurobiology (Bp) 6:33-43.
8. Arron JR, Winslow MM, Poller A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR. 2006. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441:595-600. (Pubitemid 43927286)
9. Ashworth SL, Southgate EL, Sandoval RM, Meberg PJ, Bamburg JR, Molitoris BA. 2003. ADF/cofilin mediates actin cytoskeletal alterations in LLC-PK cells during ATP depletion. Am J Physiol Renal Physiol 284:F852-F862.
10. Bamburg JR, Wiggan OP. 2002. ADF/cofilin and actin dynamics in disease. Trends Cell Biol 12:598-605.
11. Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E. 1993. Abnormal Alzheimer's-like phosphorylation of tau protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett 335:171-175. (Pubitemid 24036992)
12. Bernstein BW, Chen H, Boyle JA, Bamburg JR. 2006. Formation of actin-ADF/cofilin rods transiently retards decline of mitochondrial potential and ATP in stressed neurons. Am J Physiol Cell Physiol 291:C828-C839. (Pubitemid 44771802)
13. Bernstein BW, Maloney MT, Bamburg JR. Actin and diseases of the nervous system. In: Gallo G, Lanier LL, editors. Neurobiology of Actin. Springer. In press.
14. Bershadsky AD, Gelfand VI, Svitkina TM, Tint IS. 1980. Destruction of microfilament bundles in mouse embryo fibroblasts treated with inhibitors of energy metabolism. Exp Cell Res 127:421-429.
15. 262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11:153-163.
16. Binder LI, Frankfurter A, Rebhun LI. 1985. The distribution of tau in the nervous system. J Cell Biol 101:1371-1378.
17. Bloom GS, Goldstein LSB. 1998. Cruising along microtubule highways: how membranes move through the secretory pathway. J Cell Biol 140:1277-1280.
18. Boyne LJ, Tessler A, Murray M, Fischer I. 1995. Distribution of Big tau in the central nervous system of the adult and developing rat. J Comp Neurol 358:279-293.
19. Bramham CR. 2007. Control of synaptic consolidation in the dentate gyrus: mechanisms, functions, and therapeutic implications. Prog Brain Res 163:453-471.
20. Buée L, Bussiere T, Buée-Scherrer V, Delacourte A, Hof PR. 2000. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33:95-130. (Pubitemid 30680029)
21. Busciglio J, Lorenzo A, Yankner BA. 1992. Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol Aging 13:609-612.
22. Calderwood DA, Shattil SJ, Ginsberg MH. 2000. Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling. J Biol Chem 275:22607-22610. (Pubitemid 30646138)
23. Carlisle HJ, Manzerra P, Marcora E, Kennedy MB. 2008. SynGAP regulates steady-state and activity-dependent phosphorylation of cofilin. J Neurosci 28:13673-13683.
24. Casanova MF, Walker LC, Whitehouse PJ, Price DL. 1985. Abnormalities of the nucleus basalis in Down's syndrome. Ann Neurol 18:310-313.
25. Cataldo AM, Barnett JL, Pieroni C, Nixon RA. 1997. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci 17:6142-6151. (Pubitemid 27329890)
26. Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA. 2000. Endocytic pathway abnormalities precede amyloid-β deposition in sporadic Alzheimer's disease and Down syndrome. Differential effects of ApoE genotype and presenilin mutations. Am J Pathol 157:277-286. (Pubitemid 30641743)
27. Cataldo AM, Petanceska S, Peterhoff CM, Terio NB, Epstein CJ, Villar A, Carlson EJ, Staufenbiel M, Nixon RA. 2003. APP gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome. J Neurosci 23:6788-6792. (Pubitemid 36951206)
28. Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, Mehta PD, Buxbaum J, Haroutunian V, Nixon RA. 2004. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol Aging 25:1263-1272. (Pubitemid 39299162)
29. Chan C, Beltzner CC, Pollard TD. 2009. Cofilin dissociates Arp2/3 complex and branches from actin filaments. Curr Biol 19:537-545.
30. Chartier-Harlin MC, Crawford F, Hamandi K, Mullan M, Goate A, Hardy J, Backhovens H, Martin JJ, Broeckhoven CV. 1991a. Screening for the beta-amyloid precursor protein mutation (APP717: Val-Ile) in extended pedigrees with early onset Alzheimer's disease. Neurosci Lett 129:134-135.
31. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M. 1991b. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353:844-846. (Pubitemid 21912637)
32. Chen H, Bernstein BW, Sneider JM, Boyle JA, Minamide LS, Bamburg JR. 2004. In vitro activity differences between proteins of the ADF/cofilin family define two distinct subgroups. Biochemistry 43:7127-7142.
33. Chen GC, Turano B, Ruest PJ, Hagel M, Settleman J, Thomas SM. 2005. Regulation of Rho and Rac signaling to the actin cytoskeleton by paxillin during Drosophila development. Mol Cell Biol 25:979-987. (Pubitemid 40165806)
34. Chen TJ, Gehler S, Shaw AE, Bamburg JR, Letourneau PC. 2006. Cdc42 participates in regulation of ADF/cofilin and retinal growth cone filopodia by brain derived neurotrophic factor. J Neurobiol 66:103-114. (Pubitemid 43100725)
35. Cho HJ, Jim SM, Youn HD, Huh K, Mook-Jung I. 2008. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT1) signaling. Aging Cell 7:137-147. (Pubitemid 351359647)
36. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH. 2005. Natural oligomers of the amyloidbeta protein specifically disrupt cognitive function. Nat Neurosci 8:79-84.
37. Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J, Kilbridge JF, Carlson EJ, Epstein CJ, Mobley WC. 2001. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci USA 98:10439-10444. (Pubitemid 32803038)
38. Davis RC, Furukawa R, Fechheimer M. 2008. A cell culture model for investigation of Hirano bodies. Acta Neuropathol 115:205-217.
39. Davis RC, Maloney MT, Minamide LS, Flynn KC, Stonebraker MA, Bamburg JR. Mapping cofilin-actin rods in stressed hippocampal slices and the role of cdc42 in amyloid β-induced rods. J Alzheimers Dis. In press.
40. De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL. 2007. Abeta oligomers induce neuronal oxidative stress through an N-methy-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:1590-1601. (Pubitemid 47100810)
41. De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, Lacor PN, Bigio EH, Jerecic J, Acton PJ, Shughrue PJ, Chen-Dodson E, Kinney GG, Klein WL. 2008. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Ab oligomers. Neurobiol Aging 29:1334-1347. (Pubitemid 351970596)
42. Deshpande A, Mina E, Glabe C, Busciglio J. 2006. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26:6011-6018. (Pubitemid 44318367)
43. Drewes G, Lichtenberg-Kraag B, Doring F, Mandelkow E-M, Biernat J, Goris J, Doree M, Mandelkow E. 1992. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J 11:2131-2138.
44. mark). J Biol Chem 270:7679-7688.
45. Duron E, Hanon O. 2008. Vascular risk factors, cognitive decline and dementia. Vasc Health Risk Manag 4:363-381. (Pubitemid 351711965)
46. Edwards DC, Sanders LC, Bokoch GM, Gill GN. 1999. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1:253-259.
47. Ehehalt R, Keller P, Haass C, Thiele C, Simons K. 2003. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160:113-123. (Pubitemid 36091721)
48. Eiseler T, Doppler H, Yan IK, Kitatani K, Mizuno K, Storz P. 2009. Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshot. Nat Cell Biol 11:545-556.
49. Fukui H, Moraes CT. 2008. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality of just an attractive hypothesis. Trends Neurosci 31:251-256.
50. Fulga TA, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, Feany MB. 2007. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol 9:139-148. (Pubitemid 46420856)
51. Galkin VE, Orlova A, Lukoyanova N, Wriggers W, Engelman EH. 2001. Actin depolymerizing factor stabilizes an existing state of F-actin and can change the tilt of F-actin subunits. J Cell Biol 153:75-86. (Pubitemid 34280195)
52. Galloway PG, Perry G, Gambetti P. 1987. Hirano body filaments contain actin and actin-associated proteins. J Neuropathol Exp Neurol 46:185-199. (Pubitemid 17037778)
53. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL. 2003. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA 100:10032-10037. (Pubitemid 37087063)
54. García-Sierra F, Wischik CM, Harrington CR, Luna-Muñoz J, Mena R. 2001. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology of Alzheimer's disease. J Chem Neuroanat 22:65-77. (Pubitemid 32695510)
55. Garvalov BK, Flynn KC, Neukirchen D, Meyn L, Teusch N, Wu X, Brakebusch C, Bamburg JR, Bradke F. 2007. Cdc42 regulates cofilin during the establishment of neuronal polarity. J Neurosci 27:13117-13129. (Pubitemid 350220488)
56. Giancotti FG, Ruoslahti E. 1999. Integrin signaling. Science 285:1028-1032.
57. Gibson PH, Tomlinson BE. 1977. Numbers of Hirano bodies in the hippocampus of normal and demented people with Alzheimer's disease. J Neurol Sci 33:199-206.
58. Glenner GG, Wong CW. 1984a. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890. (Pubitemid 14104991)
59. Glenner GG, Wong CW. 1984b. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122:1131-1135.
60. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke R, Roquis P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Owen M, Hardy J. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706. (Pubitemid 21912142)
61. Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA. 1989a. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 8:393-399. (Pubitemid 19274956)
62. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. 1989b. Multiple forms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3:519-526.
63. Goedert M, Cohen ES, Jakes R, Cohen P. 1992. p42 map kinase phosphorylation sites in MT-associated protein tau are dephosphorylated by protein phosphatase 2A: implications for Alzheimer's disease. FEBS Lett 312:95-99.
64. Goedert M, Jakes R, Qi Z, Wang JH, Cohen P. 1995. Protein phosphatase 2A is the major enzyme in brain that dephosphorylates τ protein phosphorylated by proline-directed protein kinases or cyclic-AMP-dependent protein kinase. J Neurochem 65:2804-2807.
65. Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA. 1996. Assembly of microtubule-associated protein tau into Alzheimer's-like filaments induced by sulphated glycosaminoglycans. Nature 383:550-553. (Pubitemid 26346185)
66. Gohla A, Birkenfeld J, Bokoch GM. 2005. Chronophin, a novel HAD-type serine protein phosphatase, regulates cofilin-dependent actin dynamics. Nat Cell Biol 7:21-29. (Pubitemid 40123379)
67. Goldsbury C, Mocanu MM, Thies E, Kaether C, Haass C, Keller P, Biernat J, Mandelkow E, Mandelkow EM. 2006. Inhibition of APP trafficking by tau protein does not increase the generation of amyloid-beta peptides. Traffic 7:873-888. (Pubitemid 43871776)
68. Goldsbury C, Whiteman IT, Jeong EV, Lim YA. 2008. Oxidative stress increases levels of endogenous amyloid-beta peptides secreted from primary chick brain neurons. Aging Cell 7:771-775.
69. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL. 2003. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 100:10417-10422. (Pubitemid 37071893)
70. Götz J, Chen F, van Dorpe R, Nitsch RM. 2001. Formation of neurobrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils. Science 293:1491-1495. (Pubitemid 32807681)
71. Grace EA, Busciglio J. 2003. Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy. J Neurosci 23:493-502. (Pubitemid 36139548)
72. Grace EA, Rabiner CA, Busciglio J. 2002. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease. Neuroscience 114:265-273. (Pubitemid 35247506)
73. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. 1986. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913-4917. (Pubitemid 16075509)
74. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH. 1992. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation on tau: generation of paired helical filament epitopes and neuronal localization of the kinase. Neurosci Lett 147:58-62.
75. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356. (Pubitemid 34790756)
76. Hatcher JM, Pennell KD, Miller GW. 2008. Parkinson's disease and pesticides: a toxicological perspective. Trends Pharmacol Sci 29:322-329.
77. Hayden SM, Miller PS, Brauweiler A, Bamburg JR. 1993. Analysis of the interactions of actin depolymerizing factor with G- and F-actin. Biochemistry 32:9994-10004. (Pubitemid 23312425)
78. Heredia L, Helguera P, de Olmos S, Kedikian G, Sola VF, LaFerla F, Staufenbiel M, de Olmos J, Busciglio J, Caceres A, Lorenzo A. 2006. Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease. J Neurosci 26:6533-6542. (Pubitemid 44318334)
79. Himmler A. 1989. Structure of the tau gene: alternatively spliced transcripts generate a protein family. Mol Cell Biol 9:1389-1396. (Pubitemid 19095178)
80. Hirano A. 1994. Hirano bodies and related neuronal inclusions. Neuropathol Appl Neurobiol 20:3-11. (Pubitemid 24078160)
81. Hirano A, Dembitzer HM, Kurland LT, Zimmerman HM. 1968. The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex. J Neuropathol Exp Neurol 27:167-182.
82. Hiruma H, Katakura T, Takahashi S, Ichikawa T, Kawakami T. 2003. Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J Neurosci 23:8967-8977. (Pubitemid 37210910)
83. Honkura N, Matsuzaki M, Noguchi J, Ellis-Davies GC, Kasai H. 2008. The subspine organization of actin fibers regulates the structure and plasticity of dendritic spines. Neuron 57:719-729. (Pubitemid 351335344)
84. Huang TY, Minamide LS, Bamburg JR, Bokoch GM. 2008. Chronophin mediates an ATP-sensing mechanism of cofilin dephosphorylation and neuronal cofilin-actin rod formation. Dev Cell 15:691-703.
85. Hung LW, Ciccotosto GD, Giannakis E, Tew DJ, Perez K, Masters CL, Cappai R, Wade JD, Barnham KJ. 2008. Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: abeta dimers and trimers correlate with neurotoxicity. J Neurosci 28:11950-11958.
86. Hyman BT, Weat HL, Rebeck GW, Buldyrev SV, Mantegna RN, Ukleja M, Havlin S, Stanley HE. 1995. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolpoprotein E geneotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci USA 92:3586-3590.
87. Iida K, Yahara I. 1986. Reversible induction of actin rods in mouse C3H-2K cells by incubation in salt buffers and by treatment with non-ionic detergents. Exp Cell Res 164:492-506. (Pubitemid 16042094)
88. Iida K, Iida H, Yahara I. 1986. Heat shock induction of intranuclear actin rods in cultured mammalian cells. Exp Cell Res 165:207-215. (Pubitemid 16072272)
89. Iida K, Matsumoto S, Yahara I. 1992. The KKRKK sequence is involved in heat shock-induced nuclear translocation of the 18-kDa actin-binding protein, cofilin. Cell Struct Funct 17:39-46.
90. Jang DH, Han JH, Lee SH, Lee YS, Park H, Lee SH, Kim H, Kaang BK. 2005. Cofilin expression induces cofilin-actin rod formation and disrupts synaptic structure and function in Aplysia synapses. Proc Natl Acad Sci USA 102:16072-16077. (Pubitemid 41552869)
91. Kampers T, Friedhoff P, Biernat J, Mandelkow EM. 1996. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett 399:344-349. (Pubitemid 26426879)
92. Khlistunova I, Biernat J, Wang Y, Pickhardt M, von Bergen M, Gazova Z, Mandelkow E, Mandelkow EM. 2006. Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J Biol Chem 281:1205-1214.
93. Kidd M. 1963. Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197:192-193.
94. King ME, Ahuja V, Binder LI, Kuret J. 1999. Ligand-dependent tau filament formation: implications for Alzheimer's disease progression. Biochem 38:14851-14859. (Pubitemid 129517629)
95. King ME, Kan H-M, Baas PW, Erisir A, Glabe CG, Bloom GS. 2006. Tau-dependent microtubule disassembly initiated by pre-fibrillar β-amyloid. J Cell Biol 175:541-546. (Pubitemid 44790607)
96. Kojima N, Shirao T. 2007. Synaptic dysfunction and disruption of postsynaptic drebrin-actin complex: a study of neurological disorders accompanied by cognitive deficits. Neurosci Res 58:1-5. (Pubitemid 46678494)
97. Kondo J, Honda T, Mori H, Hamada Y, Miura R, Ogawara M, Ihara Y. 1988. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron 1:827-834.
98. Kosik KS, Duffy LK, Dowling MM, Abraham C, McCluskey A, Selkoe DJ. 1984. Microtubule-associated protein 2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles. Proc Natl Acad Sci USA 81:7941-7945.
99. Kosik KS, Joachim CL, Selkoe DJ. 1986. Microtubule-associated protein tau (τ) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA 83:4044-4048. (Pubitemid 16062419)
100. Kosik KS, Orecchio LD, Binder L, Trojanowski JQ, Lee VM-Y, Lee G. 1988. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1:817-825.
101. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL. 2004. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 24:10191-10200. (Pubitemid 39492046)
102. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola K, Zhang C, Finch CE, Krafft GA, Klein WL. 1998. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448-6453. (Pubitemid 28249033)
103. Lancelot E, Beal MF. 1998. Glutamate toxicity in chronic neurodegenerative disease. Prog Brain Res 116:331-347. (Pubitemid 28526944)
104. Lee G, Cowan N, Kirschner M. 1988. The primary structure and heterogeneity of Tau protein from mouse brain. Science 239:285-288. (Pubitemid 18061495)
105. Lee VM, Goedert M, Trojanowski JQ. 2001. Neurodegenerative tauopathies. Ann Rev Neurosci 24:1121-1159.
106. Lewis J, Dickson DW, Lin W-L, Chisholm L, Corral A, Jones G, Yen S-H, Sahara N, Skipper L, Yager D, et al. 2001. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487-1491. (Pubitemid 32801551)
107. Luo MH, Tse SW, Memmott J, Andreadis A. 2004. Novel isoforms of tau that lack the microtubule-binding domain. J Neurochem 90:340-351. (Pubitemid 38938220)
108. Maciver SK, Harrington CR. 1995. Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies. Neuroreport 6:1985-1988.
109. Maloney MT, Bamburg JR. 2007. Cofilin-mediated neurodegeneration in Alzheimer's disease and other amyloidopathies. Mol Neurobiol 35:21-44.
110. Maloney MT, Minamide LS, Kinley AW, Boyle JA, Bamburg JR. 2005. Beta-secretase-cleaved amyloid precursor protein accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease. J Neurosci 25:11313-11321.
111. Mandelkow EM, Drewes G, Biernat J, Gustke N, Van Lint J, Vandenheede JR, Mandelkow E. 1992. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett 314:315-321. (Pubitemid 23005680)
112. Mann DM, Yates PO, Marcyniuk B. 1984. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol 10:185-207. (Pubitemid 14121330)
113. Masliah E. 2000. The role of synaptic proteins in Alzheimer's disease. Ann N Y Acad Sci 924:68-75. (Pubitemid 32050185)
114. Maselli AG, Davis R, Thomson SAM, Davis RC, Fechheimer M. 2002. Formation of Hirano bodies in Dictyostelium and mammalian cells induced by expression of a modified form of an actin-crosslinking protein. J Cell Sci 115:1939-1949. (Pubitemid 34567255)
115. Mattson MP. 2004. Pathways towards and away from Alzheimer's disease. Nature 430:631-639. (Pubitemid 39061671)
116. McGough A, Pope B, Chiu W, Weeds A. 1997. Cofilin changes the twist of F-actin: implications for actin filament dynamics and cellular function. J Cell Biol 138:771-781. (Pubitemid 27365041)
117. Meberg PJ, Ono S, Minamide LS, Takahashi M, Bamburg JR. 1998. Actin depolymerizing factor and cofilin phosphorylation dynamics: response to signals that regulate neurite extension. Cell Motil Cytoskeleton 39:172-190. (Pubitemid 28079648)
118. Minamide LS, Striegl AM, Boyle JA, Meberg PJ, Bamburg JR. 2000. Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal neurite function. Nat Cell Biol 2:628-636.
119. Mitake S, Ojika K, Hirano A. 1997. Hirano bodies and Alzheimer's disease. Kaohsiung J Med Sci 13:10-18.
120. Morgan TE, Lockerbie RO, Minamide LS, Browning MD, Bamburg JR. 1993. Isolation and characterization of a regulated form of actin depolymerizing factor. J Cell Biol 122:623-633. (Pubitemid 23226679)
121. Moriyama K, Iida K, Yahara I. 1996. Phosphorylation of ser-3 of cofilin regulates its essential function on actin. Genes Cells 1:73-86. (Pubitemid 126673108)
122. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. 2000. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20:4050-4058. (Pubitemid 30365675)
123. Mufson EJ, Bothwell M, Kordower JH. 1989. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain. Exp Neurol 105:221-232. (Pubitemid 19232573)
124. Murrell J, Farlow M, Ghetti B, Benson MD. 1991. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254:97-99. (Pubitemid 21917324)
125. Neve RL, Harris P, Kosik KS, Kurnit DM, Donlon TA. 1986. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of genes for tau and microtubule-associated protein 2. Mol Brain Res 1:271-280. (Pubitemid 17220131)
126. Nishida E, Iida K, Yonezawa N, Koyasu S, Yahara I, Sakai H. 1987. Cofilin is a component of intranuclear and cytoplasmic actin rods induced in cultured cells. Proc Natl Acad Sci USA 84:5262-5266.
127. Niwa R, Nagata-Ohashi K, Takeichi M, Mizuno K, Uemura T. 2002. Control of actin reorganization by Slingshot, a family of phosphatases that dephosphorylate ADF/cofilin. Cell 108:233-246. (Pubitemid 34161143)
128. Novak M, Kabat J, Wischik CM. 1993. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 12:365-370. (Pubitemid 23042416)
129. Nukina N, Ihara Y. 1986. One of the antigenic determinants of paired helical filaments is related to tau protein. J Biochem 99:1541-1544.
130. Nunomura A, Chiba S, Eto M, Saito M, Makino I, Miyagishi T. 1996. Apolipoprotein E polymorphism and susceptibility to early- and late-onset sproadic Alzheimer's disease in Hokkaido, the northern part of Japan. Neurosci Lett 206:17-20. (Pubitemid 26084719)
131. Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, Vassar R, Disterhoft JF. 2006. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Eur J Neurosci 23:251-260.
132. Ohta Y, Nishida E, Sakai H, Miyamoto E. 1989. Dephosphorylation of cofilin accompanies heat shock-induced nuclear accumulation of cofilin. J Biol Chem 264:16143-16148. (Pubitemid 19238376)
133. Perry G, Rizzuto N, Autilio-Gambetti L, Gambetti P. 1985. Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc Natl Acad Sci USA 82:3916-3920. (Pubitemid 15246464)
134. Peterson C, Kress Y, Valle R, Goldman JE. 1988. High molecular weight microtubule-associated proteins bind to actin lattices (Hirano bodies). Acta Neuropathol (Berl) 77:168-174. (Pubitemid 19015554)
135. Preuss U, Biernat J, Mandelkow EM, Mandelkow E. 1997. The jaws model of tau-microtubule interaction examined in CHO cells. J Cell Sci 110 (Part 6):789-800. (Pubitemid 27156328)
136. Price DL, Sisodia SS, Gandy SE. 1995. Amyloid beta amyloidosis in Alzheimer's disease. Curr Opin Neurol 8:268-274.
137. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A. 2002. Tau is essential to β-amyloid-induced neurotoxicity. Proc Natl Acad Sci USA 99:6364-6369.
138. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L. 2007. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316:750-754. (Pubitemid 46717684)
139. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD. 1993. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:9649-9653. (Pubitemid 23315843)
140. Schmidt ML, Lee VM, Trojanowsk JQ. 1989. Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus. Lab Invest 60:513-522.
141. Schochet SS, Jr, McCormick WF. 1972. Ultrastructure of Hirano bodies. Acta Neuropathol (Berl) 21:50-60.
142. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. 2007. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866-2875. (Pubitemid 46438992)
143. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ. 2008. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14:837-842.
144. Shim KS, Lubec G. 2002. Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome. Neurosci Lett 324:209-212. (Pubitemid 34493871)
145. Sisodia SS, Price DL. 1995. Role of the beta-amyloid protein in Alzheimer's disease. FASEB J 9:366-370.
146. Sofroniew MV, Howe CL, Mobley WC. 2001. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24:1217-1281. (Pubitemid 32695259)
147. Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mumby MC. 1996. Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A. Neuron 17:1201-1207. (Pubitemid 27021104)
148. Sontag E, Nunbhakdi-Craig V, Lee G, Brandt R, Kamibayashi C, Kuret J, White CL, III, Mumby MC, Bloom GS. 1999. Molecular interactions among protein phosphatase 2A, tau and microtubules: implications for the regulation of tau phosphorylation and the development of tauopathies. J Biol Chem 274:25490-25498. (Pubitemid 129530718)
149. Soosairajah J, Maiti S, Wiggan O, Sarmiere P, Moussi N, Sarcevic B, Sampath R, Bamburg JR, Bernard O. 2005. Interplay between componets of a novel LIM kinase-slingshot phosphatase complex regulates cofilin. EMBO J 24:473-486. (Pubitemid 40343250)
150. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981. (Pubitemid 23069980)
151. Sun X, Tong Y, Qing H, Chen CH, Song W. 2006a. Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome. FASEB J 20:1361-1368. (Pubitemid 44943844)
152. Sun X, He G, Song W. 2006b. BACE2 as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome. FASEB J 20:1369-1376. (Pubitemid 44943845)
153. Takeda A, Smith MA, Avila J, Nunomura A, Siedlak SL, Zhu X, Perry G, Sayre LM. 2000. In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of τ induced by 4-hydroxy-2-nonenal modification. J Neurochem 75:1234-1241.
154. Tanzi RE, Bertram L. 2005. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120:545-555. (Pubitemid 40269768)
155. Tomonaga M. 1974. Ultrastructure of Hirano bodies. Acta Neuropathol (Berl) 28:365-366.
156. Toshima J, Toshima JY, Amano T, Yang N, Narumiya S, Mizuno K. 2001. Cofilin phosphorylation by protein kinase testicular protein kinase 1 and its role in integrin-mediated actin reorganzation and focal adhesion formation. Mol Biol Cell 12:1131-1145. (Pubitemid 33052004)
157. Turner CE. 2000. Paxillin and focal adhesion signaling. Nat Cell Biol 2:E231-E236.
158. Tytell M, Black MM, Garner JA, Lasek RJ. 1981. Axonal transport: each of the major rate components consist of distinct macromolecular complexes. Science 214:179-181. (Pubitemid 12243412)
159. Velasco ME, Smith MA, Siedlak SL, Nunomura A, Perry G. 1998. Striation is the characteristic abnormality in Alzheimer disease. Brain Res 813:329-333. (Pubitemid 29009649)
160. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. 2002. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535-539. (Pubitemid 34288854)
161. Wang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, Viola KL, Klein WL, Stine WB, Krafft GA, Trommer BL. 2002. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924:133-140. (Pubitemid 34102301)
162. Wang YP, Biernat J, Pickhardt M, Mandelkow E, Mandelkow EM. 2007. Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc Natl Acad Sci USA 104:10252-10257. (Pubitemid 47175295)
163. Wen Z, Han L, Bamburg JR, Shim S, Ming GL, Zheng JQ. 2007. BMP gradients steer nerve growth cones by a balancing act of LIM kinase and Slingshot phosphatase on ADF/cofilin. J Cell Biol 178:107-119. (Pubitemid 47026406)
164. Whitehouse PJ, Struble RG, Clark AW, Price DL. 1982. Alzheimer disease: plaques, tangles, and the basal forebrain. Ann Neurol 12:494.
165. Whiteman IT, Cullen KM, Antao ST, Witting PK, Bamburg JR, Goldsbury C. 2008. Mitochondrial dysfuction induces the accumulation of microtubule- associated protein in Alzheimer-like striated neurites. Mol Biol Cell 19 (Suppl): Abstract 1069.
166. Wilson DM, Binder LI. 1995. Polymerization of microtubule-associated protein tau under near-physiological conditions. J Biol Chem 270:24306-24314.
167. Wilson DM, Binder LI. 1997. Free fatty acids stimulate the polymerization of tau and amyloid β peptides. Am J Pathol 150:2181-2195.
168. Wischik CM, Crowther RA, Stewart M, Roth M. 1985. Subunit structure of paired helical filaments in Alzheimer's disease. J Cell Biol 100:1905-1912. (Pubitemid 15042085)
169. Wood JG, Mirra SS, Pollock NJ, Binder LI. 1986. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc Natl Acad Sci USA 83:4040-4043. (Pubitemid 16062418)
170. Yang AJ, Knauer M, Burdick DA, Glabe C. 1995. Intracellular A beta 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J Biol Chem 270:14786-14792.
171. Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K, Nishida E, Mizuno K. 1998. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393:809-812. (Pubitemid 28299495)
172. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH, Mohan PS, Mercken M, Farmery MR, Tjernberg LO, Jiang Y, Duff K, Uchiyama Y, Naslund J, Mathews PM, Cataldo AM, Nixon RA. 2005. Macroautophagy - a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 171:87-98. (Pubitemid 41434604)
173. Zhao L, Ma QL, Calon F, Harris-White ME, Yang F, Lim GP, Morihara T, Ubeda OJ, Ambegaokar S, Hansen JE, Weisbart RH, Teter B, Frautschy SA, Cole GM. 2006. Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat Neurosci 9:234-242. (Pubitemid 43164547)
174. Zhao WQ, Townsend M. 2009. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Biochim Biophys Acta 1792:482-496.
175. Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ, Krafft GA, Klein WL. 2008. Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 22:246-260.